Related Experiment Videos
[Depression and heart failure - a dangerous combination]
Insights
Depression is common in heart failure patients, impacting quality of life and clinical outcomes. While antidepressants show no benefit, therapies like physical training and cognitive behavioral therapy improve symptoms and prognosis.
Area of Science:
- Cardiology
- Psychiatry
- Public Health
Background:
- Depression frequently co-occurs with heart failure, significantly diminishing patient quality of life and worsening clinical outcomes.
- Both heart failure and depression are prevalent conditions with rising incidence and healthcare costs, highlighting their substantial socio-economic impact.
- Interconnected biological and behavioral factors, including reduced treatment adherence in depressed heart failure patients, and shared genetic predispositions are implicated in their pathophysiology.
Purpose of the Study:
- To review the interplay between depression and heart failure.
- To assess the efficacy of various treatment modalities for comorbid depression in heart failure patients.
Main Methods:
- Literature review examining the relationship between depression and heart failure.
- Analysis of evidence regarding treatment outcomes for comorbid depression in heart failure.
Main Results:
- Depression negatively affects heart failure prognosis and quality of life.
- Antidepressant pharmacotherapy has not demonstrated efficacy in improving depressive symptoms, mortality, or morbidity in heart failure patients.
- Physical training, cognitive behavioral therapy, and comprehensive disease management have shown promise in improving symptoms and/or prognosis in individual studies.
Conclusions:
- Depression is a significant comorbidity in heart failure with considerable clinical and socio-economic relevance.
- Current evidence does not support antidepressant pharmacotherapy for comorbid depression in heart failure.
- Non-pharmacological interventions like physical training and CBT offer potential benefits for managing depression in heart failure.
Abstract:
Depression is common in heart failure and associated with impaired quality of life. It impacts adversely on clinical outcomes. Both diseases are widespread in the general population with increasing prevalence and treatment costs. They are therefore also of socio-economic relevance. Various interrelated biological and behavioral factors (e.g. lower treatment adherence in depressed patients with heart failure) seem to play a pathophysiological role, and there is growing evidence that both diseases may also share genetic susceptibilities. Simple screening tools ease depression diagnosis in clinical practice, although the clinical profile of both disorders overlaps. To date, there is no evidence that antidepressant pharmacotherapy improves depressive symptoms, mortality and morbidity in patients with heart failure and comorbid depression, but physical training, cognitive behavioral therapy and comprehensive disease management improved symptoms and/or prognosis in individual randomized studies.